Clay Thorp

Insider Reports History

Entity
Individual
Location
C/O Hatteras Venture Partners III, Lp, 280 S. Mangum St., Suite 350, Durham, NC
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Clay Thorp:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vigil Neuroscience, Inc. Director Common Stock 1.56M $5.84M $3.75 May 17, 2022 By Hatteras Venture Partners VI, L.P.
Clearside Biomedical, Inc. Director Common Stock 3.55M $4.5M $1.27 Sep 25, 2023 Indirect
Clearside Biomedical, Inc. Director Common Stock 40.5K $51.5K $1.27 Sep 25, 2023 Direct
Vigil Neuroscience, Inc. Director Common Stock 3K $11.3K $3.75 May 16, 2022 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 3.55M May 19, 2023 Indirect
Clearside Biomedical, Inc. Director Stock Option (right to buy) 45K Jun 20, 2024 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 36.7K May 19, 2023 Direct
PhaseBio Pharmaceuticals Inc Director Restricted Stock Units 0 May 19, 2023 Direct

Insider Reports Filed by Clay Thorp

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLSD Clearside Biomedical, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
CLSD Clearside Biomedical, Inc. Sep 25, 2023 1 $8.6K 4 Sep 25, 2023 Director
CLSD Clearside Biomedical, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
PHASQ PhaseBio Pharmaceuticals Inc May 19, 2023 2 $0 4 May 19, 2023 Director
CLSD Clearside Biomedical, Inc. Dec 21, 2022 1 $14.3K 4 Dec 21, 2022 Director
CLSD Clearside Biomedical, Inc. Dec 15, 2022 2 $0 4 Dec 19, 2022 Director
CLSD Clearside Biomedical, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
PHASQ PhaseBio Pharmaceuticals Inc May 19, 2022 2 $0 4 May 20, 2022 Director
VIGL Vigil Neuroscience, Inc. May 16, 2022 2 $104K 4 May 17, 2022 Director
VIGL Vigil Neuroscience, Inc. Mar 28, 2022 1 $21.6K 4 Mar 28, 2022 Director
VIGL Vigil Neuroscience, Inc. Jan 11, 2022 4 $3.71M 4 Jan 11, 2022 Director
VIGL Vigil Neuroscience, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 Director
PHASQ PhaseBio Pharmaceuticals Inc Aug 18, 2021 1 $30K 4 Aug 18, 2021 Director
CLSD Clearside Biomedical, Inc. Jun 10, 2021 1 $0 4 Jun 11, 2021 Director
PHASQ PhaseBio Pharmaceuticals Inc Jun 3, 2021 1 $0 4 Jun 4, 2021 Director
CLSD Clearside Biomedical, Inc. Feb 10, 2021 1 -$146K 4/A Dec 19, 2022 Director